Skip to main content
Signal8

ALTERITY THERAPEUTICS LTD (PRNAF)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Alterity Therapeutics Limited logo

Alterity Therapeutics Limited

OTC:PRNAFSub-class of ATHEHealthcare
+0.00%$0.2000
CLOSED
Mkt Cap$3.82M
EV-
Float-
O/S19.09M
VOL3K sh
$ Vol$500
RVOL0.50×
Inst Own-
SI<0.1%
Net Cash/Sh-
Dilution
Alterity Therapeutics Limited logoOTC:PRNAFClosed$0.2000+0.00%
Historical Data
DateOpenHighLowCloseVolume
Nov 11, 20260.20000.20000.20000.20002,500
Nov 5, 20260.20000.20000.20000.20005,000
Nov 3, 20260.20000.24220.20000.24227,500
Oct 12, 20260.25000.25000.25000.25002,500
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
1
HOLD
0
SELL
0
TOTAL1
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
--
Institutional
(0)
--
Insiderⓘ
(0)
--
5%+ Owners
(0)
--
Unattributed (incl. retail)ⓘ
Issuer-wide via ATHE
2.0%
Institutional
(23)
61.2%
Insider
(1)
0.0%
5%+ Owners
(0)
Sources:
About

Alterity Therapeutics Limited, an Australian biopharmaceutical firm, focuses on the discovery and development of novel drug treatments for various neurological disorders, such as Alzheimer's, Huntington's, and Parkinson's diseases.

Its prominent experimental therapy, ATH434, has completed Phase I clinical trials targeting Parkinson's disease.

The company is also advancing PBT2, a compound that has successfully undergone Phase IIa clinical testing for Alzheimer's disease. Established in 1997, the entity was formerly known as Prana Biotechnology Limited before rebranding to Alterity Therapeutics Limited in April 2019, and its main operations are based in Melbourne, Australia.

Key Metrics
Market Cap$3.82M
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership-

No 13F filer reports a position yet. 13F reports are quarterly and are filed up to 45 days after the quarter ends.

Parent ATHE: 2.03% · 23 13F holders

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryAUAU
IPO DateSep 29, 2003
Shares Outstanding19.09M
Authorized Shares
Float-
52-Week Range
$0.0450$0.5501
$0.2000(31st percentile)
Volume
Average Daily Volume5.00K
2.50K today vs 5.00K avg(-50%)

30d Avg

5.00K

60d Avg

4.38K

90d Avg

4.00K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...

Alterity Therapeutics Ltd (OTC: PRNAF) traded at $0.2000 on Nov 11, 2026, unchanged from the previous close of $0.2000. 52-week range: $0.0450 to $0.5501. The company is in the Healthcare sector (Biotechnology).